• Share
  • Email
  • Print
Life Sciences

Companies in the life sciences arena face unique challenges: complex domestic and foreign regulations, volatile capital and commercial market trends, and paradigm-shattering scientific advances. Many emerging life sciences clients tend to be growth- and risk-oriented, often with tight cash positions. They require lawyers who are responsive, committed, and focused, as well as value- and solutions-driven. K&L Gates’ life sciences lawyers have a keen sensitivity to these issues. The strength and breadth of the group — across legal practice areas, geographical regions, and life sciences industries — continually expose the lawyers to new information, while the group’s shared commitment enables rapid information dissemination.

K&L Gates’ Life Sciences team is an international network of more than 115 lawyers experienced in solving the complex legal and regulatory issues facing pharmaceutical, biotechnology, health care, and medical device companies around the world. Our team practices in areas as diverse as intellectual property, corporate and securities, regulatory compliance, litigation, employment and executive compensation, environmental, real estate, and tax law. Our life sciences lawyers possess an impressive complement of pharmaceutical, diagnostic, and medical device-related business experience and a deep technical background in molecular and cell biology.

The Life Sciences practice represents a variety of clients, from private equity and venture capital funds, to angel investors, biotechnology start-ups, medical device companies, and academic and research institutions. Our capabilities span the entire spectrum of legal needs of life sciences companies, allowing us to provide integrated advice that result in efficiencies of both cost and precious management time. Our core teams include strategic alliances, licensing, and intellectual property; corporate and transactional; FDA and other regulatory issues; litigation and insurance coverage; and privacy, information management, and data protection.

Areas of Practice

NameTitleOfficeContact
Partner
P +1.412.355.8261
Partner
P +1.206.370.7653
Special Counsel
P +61.3.9205.2046
Practice Area Leader - Intellectual Property
P +1.312.807.4204
Partner
P +1.617.261.3108
Partner
P +1.312.807.4370
Partner
P +1.919.466.1109
Partner
P +1.843.579.5661
Partner
P +1.617.261.3115
Partner
P +1.973.848.4052
Patent Attorney
P +61.2.9513.2497
Of Counsel
P +1.919.743.7303
Partner
P +1.973.848.4048
Government Affairs Counselor
P +1.202.661.3882
Partner
P +1.919.466.1269
Partner
P +1.949.623.3559
Partner
P +1.919.466.1110
Partner
P +1.206.370.7947
Administrative Partner (Taipei)
P +886.2.2326.5125
Partner
P +61.3.9640.4329
Partner
P +1.212.536.3910
Patent Agent
P +1.949.623.3564
Counsel
P +1.617.951.9080
Partner
P +61.2.9513.2308
Partner
P +1.949.623.3519
Partner
P +1.919.466.1115
Partner
P +1.650.798.6719
Staff Lawyer
P +1.617.951.9165
Special Counsel
P +61.3.9205.2107
Partner
P +1.949.623.3576
Partner
P +1.973.848.4064
Special Counsel
P +44.(0)20.7360.8182
Partner
P +1.206.370.7809
Of Counsel
P +48.22.653.4206
Government Affairs Advisor
P +1.412.355.8910
Partner
P +61.2.9513.2484
Partner
P +61.2.9513.2510
Partner
P +61.3.9640.4410
Partner
P +1.206.370.7816
Partner
P +61.2.9513.2428
Partner
P +1.919.743.7315
Associate
P +1.949.623.3563
Administrative Partner (Orange County)
P +1.949.623.3531
Partner
P +61.3.9205.2014
Counsel
P +1.919.743.7341
Partner
P +1.919.466.1117
Partner
P +49.(0)69.945.196.260
Partner
P +1.206.370.7955
Partner
P +1.212.536.3930
Partner
P +1.973.848.4129
Partner
P +1.704.331.7582
Partner
P +1.973.848.4020
Special Counsel
P +61.2.9513.2437
Associate
P +1.919.314.5609
Partner
P +1.617.261.3148
Partner
P +1.212.536.4006
Partner
P +1.617.261.3150
Partner
P +971.4.427.2714
Partner
P +1.415.882.8031
Associate
P +1.949.623.3575
Lawyer
P +61.2.9513.2539
Partner
P +1.650.798.6751
Practice Area Leader - Corporate & Transactional
P +1.212.536.4887
Showing 1-10 of 24 results
1 | 2 | 3   Next >
Corporate and Transactional
Negotiating clinical research agreements in behalf of CROs, university hospitals, and investigators with pharmaceutical and biotechnology drug sponsors.
Negotiating contract manufacturing agreements on behalf of drug sponsors seeking partners post-NDA approval.
Representing numerous emerging life sciences companies in connection with fund-raising from angel, venture capital, and other institutional investors.
Representing healthcare providers in complex financings and regulatory approval for expansion of facilities.
Negotiating the license of commercialization and development rights with respect to breakthrough oral disease prevention technologies on behalf of the research arm of a world-renowned school of dental medicine.
Negotiating and drafting numerous licensing, option, and collaboration agreements for pharmaceutical companies.
Representing a well-known biotechnology company from its incorporation through its initial public offering through its product development licenses with major pharmaceutical companies, one of which broke all previous dollar value records in biotech-pharma development arrangements.
Counseling universities and other research centers on commercialization of research and establishment of for-profit companies.
Representing venture capital investors in connection with direct investments in specialty pharma and other life sciences portfolio companies.
Government and Regulatory
Providing critical legal support for a major pharmaceutical trade association's legislative initiative.